GE launches $250 million fund for device investments
This article was originally published in The Gray Sheet
GE Healthcare plans to invest $250 million in "high potential" health care technology companies through its GE Healthymagination Fund, launched Oct. 21. A component of the firm's recently unveiled Healthymagination initiative, a global commitment "to deliver better health care to more people at lower cost," the equity investment fund will target three broad areas for investment: diagnostics, health care information technology and life sciences, according to the company (1"The Gray Sheet" May 11, 2009)
You may also be interested in...
GE will shift more of its health care R&D spending toward lower-priced medical products over the next six years under an initiative announced May 7
Dispatches from a world turned upside down include FDA expressing confidence in Chinese manufacturers – to make their GDUFA payments; projections of drug shortages for ventilator patients; and the launch of new hydroxychloroquine studies.
A Phase III trial testing the antibody-drug conjugate sacituzumab govitecan was stopped early for efficacy, boding well for the BLA pending at the US FDA.